A recent study has indicated that molecular chaperones may also be involved in AD pathology, and increasing evidence indicates that Hsp–UPS-mediated aggregate clearance is the pivotal mechanism of AD treatment16. The gene discussed is HSP90B2P; the disease is Alzheimer disease.